Due to the timely nature of this topic, we are providing an advanced release of this article, ahead of the October-December 2025 issue publication. This article is subject to changes
Dear Editor: Although poststroke psychosis is a reasonably well-established clinical phenomenon,1 few articles describing the development of psychotic symptoms on the background of a perinatal stroke history or other anoxic
Dear Editor: I read with interest the article by Allen et al1 about a 19-year-old male transgender patient who developed seizures after intentionally taking 2,000mg of fluoxetine. His medical history
Dear Editor: We thank the author for their thoughtful and insightful comments on our case report.1 We fully agree that fluoxetine has a known potential to trigger seizures, especially in
by Rahi Patel, MD; Amin Ashraf, BS; Nicholas Myers, BS; and Nita Bhatt, MD, MPH Dr. Patel is with Beth Israel Deaconess Medical Center at Harvard Medical School in Boston,
Innov Clin Neurosci. 2025;22(7–9):18–23. by Robert G. Bashuk, MD; Stephen L. Scranton, MD, FACP; Robert S. Allen, AuD, and Marco Cecchi, PhD Drs. Bashuk and Allen are with the Concussion
Innov Clin Neurosci. 2025;22(7–9):24–27. by Muqadas Fatima, MS, and Uzma Ilyas, PhD Ms. Fatima is serving as Lecturer at National University of Modern Languages (NUML) in Lahore, Pakistan. Dr. Ilyas
Innov Clin Neurosci. 2025;22(7–9):32–39. by Ray M. Merrill, PhD, MPH Dr. Merrill is with the Department of Public Health in the College of Life Sciences at Brigham Young University in
Innov Clin Neurosci. 2025;22(7–9):40–41. by Adil Tumbi, MD; Amit Mistry, MD; BreAnna-Anh Le, BS; and Steven Lippmann, MD Drs. Tumbi and Mistry are with the Oklahoma City Veteran Affairs Health
Innov Clin Neurosci. 2025;22(7–9):42–43. by Akemini “Kem” Isang, RN, JD Ms. Isang is a Risk Manager at Professional Risk Management Services (PRMS). FUNDING: No funding was provided for the preparation
Innov Clin Neurosci. 2025;22(4–6):11–13. Dear Editor: We read with interest the article by Free et al1 about a 32-year-old female patient with a history of migraine, gastroesophageal reflux disease (GERD)
Innov Clin Neurosci. 2025;22(4–6):11–13. Dear Editor: We greatly appreciate the letter to the editor regarding the article “Compulsive Biting and Chewing with Mixed Amphetamine Salts: A Case Report” by Free
Innov Clin Neurosci. 2025;22(4–6):11–13. Dear Editor: Approximately 15 years have passed since functional near-infrared spectroscopy (fNIRS) was approved for use as an auxiliary diagnostic tool for the differential diagnosis of
by Samara White, PharmD; Tammie Lee Demler, PharmD, MBA, BCGP, BCPP; and Eileen Trigoboff, RN, PMHCNS-BC, DNS, DABFN Drs. White and Demler are with The New York State Office of
by Ahmed Aboraya, MD, DrPH; Daniel Elswick, MD; James Berry, DO; Dilip Chandran, MD; Cheryl Hill, MD; Wanhong Zheng, MD; Jeremy D. Hustead, MD; Dorothy Van Oppen, MD; Vishal Patel,
by Rabeel Ahmad, DO; Samantha Shor, DO; Genesy Aickareth, BS; Roselyn Chiyezhan, BS; Meghna Mathews, BS; Isabel Chacko, BS; Brett Pontelandolfo, BS; and Joanne Mathews, MD Dr. Ahmad is with
by Larrilyn Grant, MD, MS; Kari Harper, MD; and Julie P. Gentile, MD, MBA All authors are with the Department of Psychiatry at Wright State University in Dayton, Ohio. FUNDING:
by Devendra Kumar Singh Varshney, PhD; Manju Agrawal, PhD; Rakesh Kumar Tripathi, PhD, MPhil; and Satish Rasaily, MD Dr. Varshney is with DCV Institute of Indology in Lucknow, India. Dr.
by Charles D. Cash, JD, LLM Mr. Cash is Associate Director of Risk Management at Professional Risk Management Services (PRMS). FUNDING: No funding was provided for the preparation of this
Helping Exceptionally Sensitive Patients See Their Sensitivity as a Gift
Innov Clin Neurosci. 2025;22(7–9):28–31. by Edmund G. Howe, MD, JD Dr. Howe is with Uniformed Services University of the Health Sciences in Bethesda, Maryland. FUNDING: No funding was provided for
Read More